Skip to main content
. 2016 May 6;5(3):288–299. doi: 10.5527/wjn.v5.i3.288

Table 3.

Markers of proliferation and apoptosis in the experimental groups

Group n Cortical PCNA (%) BrdU + TECs (cells/mm2) TUNEL + TECs (Field 1) TUNEL + TECs (Field 4)
Control 9 0 ± 0 (0, 0-0) 0.2 ± 0.0 (0.2, 0-0.2) 6.9 ± 2.5 (8, 0-11.2) 2.7 ± 2.1 (0, 0-5.6)
PON d 2 C6+ 6 0.24 ± 0.061 8.8 ± 2.71 - -
(0.28, 0.13-0.36) (8.9, 2.7-15.3)
PON d 2 C6- 5 0.21 ± 0.071 6.8 ± 3.11 - -
(0.18, 0.14-0.30) (6.4, 0.6-13.2)
PON d 4 C6+ 6 0.34 ± 0.081 4.6 ± 0.81 - -
(0.30, 0.09-0.48) (5.2, 3.4-7.4)
PON d 4 C6- 6 0.19 ± 0.041 3.2 ± 0.51 - -
(0.18, 0.14-0.30) (1.2, 1.7-3.7)
PON d 8 C6+ 8 0.15 ± 0.051 2.4 ± 0.71 13.4 ± 3.3 10.0 ± 2.61
(0.11, 0.03-0.16) (3.1, 0-4.1) (12.8, 5.6-16.8) (9.6, 5.6-17.6)
PON d 8 C6- 9 0.09 ± 0.031 2.0 ± 0.71 11.4 ± 3.7 7.8 ± 2.8
(0.08, 0.02-0.11) (1.2, 0.1-3.7) (9.6, 0-17.6) (6.4, 0-16)

Data are expressed as mean ± SEM (median, Inter-quartile range);

1

P < 0.05 compared to control group; Field 1 was the sub-capsular cortex; Field 4 was the inner cortex/outer medulla. PCNA: Proliferating cell nuclear antigen; TUNEL: Transferase-mediated nick end-labeling; PON: Protein-overload nephropathy; TEC: Tubular epithelial cells.